Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Korean Journal of Urology ; : 847-848, 2015.
Article in English | WPRIM | ID: wpr-95479

ABSTRACT

No abstract available.


Subject(s)
Humans , Metabolic Syndrome , Prostatic Hyperplasia
2.
Korean Journal of Urology ; : 814-820, 2014.
Article in English | WPRIM | ID: wpr-219570

ABSTRACT

PURPOSE: To investigate the effect of metabolic syndrome (MetS) on the response to medical therapy of benign prostatic hyperplasia (BPH) after a 3-month period of treatment. MATERIALS AND METHODS: This was a cohort study of 100 patients, 47 with MetS and 53 without MetS, referred to either the primary care unit or referral hospital with BPH who had moderate lower urinary tract symptoms of prostate involvement and were candidates for medical treatment. Our main outcome was response to medical treatment with prazosin 1 mg twice a day and finasteride 5 mg daily in patients with BPH on the basis of International Prostate Symptom Score (IPSS). Multivariate analysis of covariance was used to compare BPH treatment response in patients with and without MetS before and after receiving treatment. RESULTS: The mean volume of the prostate was significantly higher in MetS patients than in patients without MetS (57+/-32.65 mL compared with 46.00+/-20.19 mL, p=0.036). The control group demonstrated an 11-unit reduction in IPSS, whereas those with MetS showed a reduction in the symptom score of only 6 units (p<0.001). Regarding the components of MetS separately, triglyceride (p<0.001), fasting blood sugar (p=0.001), and waist circumference (p=0.028) significantly affected the clinical progression of BPH. The observational nature of this study may be a limitation in comparison with an interventional study. CONCLUSIONS: The results of the present study showed that MetS can negatively affect the response to medical treatment of BPH. Therefore, it is necessary to consider MetS in selecting patients with BPH for drug therapy.


Subject(s)
Aged , Humans , Male , Middle Aged , Case-Control Studies , Finasteride/therapeutic use , Lower Urinary Tract Symptoms/etiology , Metabolic Syndrome/complications , Patient Selection , Prazosin/therapeutic use , Prostatic Hyperplasia/complications , Treatment Outcome , Urological Agents/therapeutic use
3.
The Korean Journal of Pain ; : 152-161, 2014.
Article in English | WPRIM | ID: wpr-188389

ABSTRACT

BACKGROUND: According to the reports of the World Health Organization 20% of world population suffer from pain and 33% of them suffer to some extent that they cannot live independently. METHODS: This is a cross-sectional study which was conducted in the emergency department (ED) of Valiasr Hospital of Arak, Iran, in order to determine the causes of delay in prescription of analgesics and to construct a model for prediction of circumstances that aggravate oligoanalgesia. Data were collected during a period of 7 days. RESULTS: Totally, 952 patients participated in this study. In order to reduce their pain intensity, 392 patients (42%) were treated. Physicians and nurses recorded the intensity of pain for 66.3% and 41.37% of patients, respectively. The mean (SD) of pain intensity according to visual analogue scale (VAS) was 8.7 (1.5) which reached to 4.4 (2.3) thirty minutes after analgesics prescription. Median and mean (SD) of delay time in injection of analgesics after the physician's order were 60.0 and 45.6 (63.35) minutes, respectively. The linear regression model suggested that when the attending physician was male or intern and patient was from rural areas the delay was longer. CONCLUSIONS: We propose further studies about analgesics administration based on medical guidelines in the shortest possible time and also to train physicians and nurses about pain assessment methods and analgesic prescription.


Subject(s)
Humans , Male , Analgesics , Attitude of Health Personnel , Cross-Sectional Studies , Emergencies , Emergency Medicine , Emergency Service, Hospital , Iran , Linear Models , Narcotics , Pain Measurement , Practice Patterns, Physicians' , Prescriptions , World Health Organization
4.
IJRM-Iranian Journal of Reproductive Medicine. 2012; 10 (6): 517-522
in English | IMEMR | ID: emr-156004

ABSTRACT

Given the paucity of data on possible testis changes in opioid dependents, we sought to compare the testis volumes between a group of opium dependents and a group of healthy controls. Comparison of testis volume between opium dependents and healthy controls. This case-control study recruited 100 men with opium dependency [cases] and 100 healthy men [controls] in Iran, in 2008. A checklist containing questions about age, height, weight, daily amount of cigarette use, and duration of cigarette use for all the participants as well as daily amount of opium use [grams] and duration of opium use [years] for the case group was completed. Additionally, the dimensions of each testis were measured by a single person using calipers, and the mean of the left and right testes volume was compared between these two groups. The mean of the testis volumes in the case group was significantly lower than that of the case group [11.2 +/- 2.2 and 25.1 +/- 2.7cm[3], p<0.001]. The results of the ANCOVA test showed that even after the omission of the cigarette smoking effect [p=0.454], the testis volume remained lower in the opium dependents [R[2]=0.884, p<0.001]. In the case group, there were significant reverse correlations between testis volume and age [r=-0.404, p<0.001], daily amount of opium use [r=-0/207, p=0.039] and duration of opium use [r=-0.421, p<0.001]. We found that the testis volume in the male opium dependents was lower than that of the healthy controls. We would recommend that future studies into the impact of drugs on the testis dimensions pay heed to possible histological changes in the testes owing to opium dependency

5.
IJKD-Iranian Journal of Kidney Diseases. 2010; 4 (2): 106-110
in English | IMEMR | ID: emr-105443

ABSTRACT

Abu Bakr Mohammad Ibn Zakariya Razi, known in the west as Rhazes [865 to 925 AD], was born in the ancient city of Rayy, near Tehran, Iran. He was a renowned physician in medical history and not only followed Hippocrates and Galen, but also greatly extended the analytical approach of his predecessors. Based on the existing documents, he was known as the most distinguished character in the world of medicine up to the 17th century. A great number of innovations and pioneering works in the medical science have been recorded in the name of Rhazes. His fundamental works in urology as part of his research in the realm of medicine have remained unknown. Pathophysiology of the urinary tract, venereal diseases, and kidney and bladder calculi are among his main interests in this field. He also purposed and developed methods for diagnosis and treatment of kidney calculi for the first time in medical history. He also presented a very exact and precise description of neuropathic bladder followed by vertebral fracture. He advanced urine analysis and studied function and diseases of the kidneys. Rhazes recommendations for the prevention of calculi are quite scientific and practical and in accordance with current recommendations to avoid hypercalciuria and increased saturation of urine. Rhazes was not only one of the most important Persian physician-philosophers of his era, but for centuries, his writings became fundamental teaching texts in European medical schools. Some important aspects of his contributions to medicine are reviewed


Subject(s)
Humans , History of Medicine , Urinalysis , Philosophy , Kidney Calculi/therapy , Kidney Calculi/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL